000 01341 a2200373 4500
005 20250513112514.0
264 0 _c19970331
008 199703s 0 0 eng d
022 _a1350-0872
024 7 _a10.1099/00221287-143-2-519
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSamuels, D Scott
245 0 0 _aOligonucleotide-mediated genetic transformation of Borrelia burgdorferi.
_h[electronic resource]
260 _bMicrobiology (Reading, England)
_cFeb 1997
300 _a519-522 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAminocoumarins
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aBorrelia burgdorferi Group
_xgenetics
650 0 4 _aCoumarins
_xpharmacology
650 0 4 _aDNA Gyrase
650 0 4 _aDNA Topoisomerases, Type II
_xgenetics
650 0 4 _aDNA, Single-Stranded
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aElectroporation
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aMutagenesis, Site-Directed
650 0 4 _aOligonucleotides
650 0 4 _aTopoisomerase II Inhibitors
650 0 4 _aTransformation, Genetic
700 1 _aGaron, Claude F
773 0 _tMicrobiology (Reading, England)
_gvol. 143 ( Pt 2)
_gp. 519-522
856 4 0 _uhttps://doi.org/10.1099/00221287-143-2-519
_zAvailable from publisher's website
999 _c9031706
_d9031706